CAH
$233.12+2.11%
as of close, Oct 5, 2026
☾ AH $233.12 +2.11%
Cardinal Health Inc.Stock · HealthcareS&P 500 Equal Weight 0.2%S&P 500 0.09%Russell 1000 0.08%US Stock Market 0.08%Russell 3000 0.08%MSCI ACWI 0.05%MSCI World 0.05%
CAH — Cardinal Health Inc. price, chart and key statistics
Technical analysis2
Overlay lines0
Addendum charts0
VolumeDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDEDEDEDED
60.080.0100.0120.0140.0160.0180.0200.0220.0240.0020.0M$233.12—20162019202120242026
2026-10-05
Price$233.12
MA20$221.53
MA50$203.18
Vol7.4M
Key stats#
Price data
- Price
- $233.12
- YTD price return
- +13.44%
- YTD total return
- +14.51%
- Next earnings
- Nov 5, 2026 · Before open
- Market cap
- 54.2B
- Enterprise value
- 59.7B
- Shares outstanding
- 232.6M
- 52W low
- $150.78
- 52W high
- $258.30
- From 52W high
- -9.75%
- From 52W low
- +54.61%
- 52W range
- 77%
- Beta
- 0.50
Volume
- Rel volume
- 0.99×
- 30D volume
- 1.7M
- 30D $ vol
- 403.2M
Insider trading
- Insider net 1W
- none
- Insider net 1M
- none
- Insider net 3M
- −$59.6M
- Insider net 1Y
- −$61.6M
Form 4 transactions by trade date, as filed; latest on file 2026-08-19.
Fundamentals
- Sales (ttm)
- 254.2B
- Sales/share
- $1,093.18
- EPS (ttm)
- $7.23
- FCF (ttm)
- 4.5B
- FCF/share
- $19.46
- Book value/share
- -$12.40
- Net margin
- 0.67%
- ROA
- 2.99%
- Current ratio
- 0.88
Growth (CAGR, ttm) · 10Y
- Sales
- +14.24%+7.44%+9.37%+7.66%
- Net income
- +9.81%+73.16%+22.92%+1.85%
- FCF
- +144.74%+24.17%+17.40%+6.09%
- Shares
- -2.61%-2.47%-4.35%-3.10%
Per-share growth (CAGR, ttm) · 10Y
- EPS
- +12.10%+79.00%+28.30%+5.29%
- Sales/share
- +17.30%+10.16%+14.34%+11.10%
- FCF/share
- +151.29%+27.32%+22.74%+9.48%
- Dividend/share
- +0.99%+1.00%+1.01%+2.79%
- Price
- +50.43%+37.42%+36.51%+11.90%
- Total return
- +51.85%+39.39%+39.32%+15.02%
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- 32.2×
- P/OI (ttm)
- 20.7×
- Fwd P/E
- 16.2×
- P/S (ttm)
- 0.2×
- P/B (mrq)
- -18.8×
- P/FCF (ttm)
- 12.0×
- EV/EBITDA (fy)
- 16.7×
- EV/Sales (ttm)
- 0.2×
- FCF yield (ttm)
- 8.35%
- Dividend yield (fwd)
- 0.89%
- Dividend yield (ttm)
- 0.88%
- Dividend/share (fwd)
- $2.06
- Buyback yield (realized, 1y)
- 2.61%
- Shareholder yield (realized, 1y)
- 3.83%
- Buyback yield (cash, ttm)
- 2.50%
- Shareholder yield (cash, ttm)
- 3.41%
Vs own 10Y history
- P/E
- 72nd
- P/OI
- 57th
- P/S
- 98th
- P/B
- 95th
- P/FCF
- 71st
Bar = where today’s multiple sits in CAH’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).
Performance · price return · as of 2026-10-05#
1D
+2.11%
5D
+5.82%
1M
-5.69%
3M
-2.44%
YTD
+13.44%
1Y
+50.93%
5Y
+374.01%
Recent filings#
- Oct 18-K · Regulation FD disclosure
- Sep 21Proxy · Annual report to shareholders
- Sep 21Proxy · Additional proxy materials
- Sep 21Proxy · Proxy statement
- Aug 19Insider sale · Hollar Jason M. (Chief Executive Officer) sold 44,529 shares for $10.5M at $233.22–$237.88
Financial statements
Open full CAH financials →Loading financial statements…
Related Healthcare#
| Ticker | Name | 1M | 1D |
|---|---|---|---|
| LLY | Eli Lilly and Company | -0.54% | +0.02% |
| JNJ | Johnson & Johnson | -8.10% | -1.21% |
| ABBV | AbbVie Inc. | +3.63% | +1.12% |
| MRK | Merck & Co. Inc. | -7.18% | -3.30% |
| UNH | UnitedHealth Group Incorporated Common Stock (DE) | -4.67% | +1.80% |
| TMO | Thermo Fisher Scientific Inc. | +10.26% | +3.35% |
| AMGN | Amgen Inc. | -7.83% | -0.01% |
| GILD | Gilead Sciences Inc. | -4.22% | -0.08% |
